DMS 114（人肺癌細(xì)胞）
-
-
-
-
- +3
英文名稱：DMS 114
貨號(hào)： CL-0752
價(jià)格： ￥1500
套餐組合價(jià)
產(chǎn)品信息
| 產(chǎn)品名稱 | DMS 114（人肺癌細(xì)胞） |
| 別稱 | DMS-114;DMS114;Darmouth Medical School 114 |
| 種屬 | 人，白人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 |
凍存液：55% 基礎(chǔ)培養(yǎng)基+40% FBS+5% DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長(zhǎng)培養(yǎng)基：Waymouth's MB 752/1+10% FBS+1% P/S 培養(yǎng)條件：氣相：空氣，95%；CO?，5%, 溫度：37℃ |
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
參考資料(來源文獻(xiàn))
| 背景描述 | The line was established from cells from a mediastinal biopsy of a patient with small cell carcinoma of the lung. The patient had not received prior therapy.The patient had not received prior therapy. The cells express HLA class I and class II antigens. Early passages of the cells were contaminated with a bovine mycoplasma (Acholeplasma laidlawii) which was cured (prior to cryopreservation) with A. laidlawii antiserum and kanamycin. |
| 年齡（性別） | 68Y;Male |
| 組織來源 | 肺 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 肺癌細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 致瘤性 | Yes; Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 10(7) cells. |
位點(diǎn)信息
鑒定圖
-
期刊：TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI：10.1016/j.taap.2024.116915
影響因子：3.8
引用產(chǎn)品： NCI-H446 [H446] 細(xì)胞, NCI-H146 [H146] 細(xì)胞, NCI-H209 [H209] 細(xì)胞, DMS 114 細(xì)胞, H1688 細(xì)胞
-
期刊：TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI：10.1016/j.taap.2024.117005
影響因子：3.3
引用產(chǎn)品： NCI-H146 [H146] 細(xì)胞, NCI-H446 [H446] 細(xì)胞, NCI-H209 [H209] 細(xì)胞, NCI-H1688 細(xì)胞, DMS 114 細(xì)胞
識(shí)別碼示意圖
